5 Minutes With: Brian Donahue

Editor’s Note: This is the first of a multi-part series of Q&As featuring Clinical Ink executives. Given the company’s unprecedented growth over the past few years, as well as the tremendous growth opportunities ahead, we’re giving Clinical Ink clients and our team another way to get to know some of our newest executive members. Sign up for email announcements to get notified of upcoming “meet and greets!”

Clinical Ink Chief Operating Officer Brian Donahue brings more than 15 years of management and leadership experience to Clinical Ink, many of them with global powerhouse, General Electric. While there, he served as chief commercial officer for a $1.5 billion imaging business for GE Healthcare. He also led initiatives that improved employee satisfaction, improved productivity, and saved the company more than $1 million annually.


In only a few short months, Brian has made great strides in positioning Clinical Ink for its next growth phase. His enthusiasm for Clinical Ink’s mission is contagious and we’re thrilled to have him on board.


We caught up with Brian recently to chat about life inside and outside our Philadelphia office.


CI: Before joining Clinical Ink as its COO, you served in leadership roles at GE for 16 years. What attracted you to Clinical Ink?

BD: The chance to join an organization that has so much potential and makes such a massive impact was very attractive to me. I wanted to be in a fast-growth, private equity-owned company that was focused on its employees and customers — with little distraction from that mission. I am excited each day about the mission and purpose of Clinical Ink, to improve patient lives by delivering solutions that connect workflows and data.


CI: As COO you get to wear multiple hats. How did you gain such a breadth of experience?
BD: During my years before Clinical Ink, I very purposely gained as much experience as possible in different functional areas and on different projects. I also aimed to solve as many different problems as possible. Being purposeful about spending time on multiple projects in multiple areas has given me the breadth of experience to solve problems here at Clinical Ink.


CI: What’s the most exciting development in clinical technology you’ve seen over the past year?
The stronger move toward decentralized trials. Not all patients can travel to sites to participate in clinical trials. Telehealth, BYOD, and other remote technologies make clinical trials accessible to a broader, more diverse population.


CI: When I’m not working, you’ll find me:

BD: Hanging out with my family — normally outside doing physical activities such as running, hiking, biking, baseball, etc.


CI: What’s your favorite quote?

BD: A Cherokee elder was teaching his young grandson about life. “A fight is going on inside me,” he said to the boy. “It is a terrible fight, and it is between two wolves. One is evil — he is anger, envy, sorrow, regret, greed, arrogance, self-pity, guilt, resentment, inferiority, lies, false pride, superiority, self-doubt, and ego. The other is good — he is joy, peace, love, hope, serenity, humility, kindness, benevolence, empathy, generosity, truth, compassion, and faith. This same fight is going on inside you — and inside every other person, too.”

The boy thought about it for a minute and then asked his grandfather, “Which wolf will win?”

The elder simply replied, “The one you feed.”

 To learn more about the people who drive Clinical Ink, visit our management team page.

Subscribe to Email Updates